サインイン 無料でサインアップします。

Adaptimmune Therapeutics Plcの浮動株式数

Adaptimmune Therapeutics Plcの浮動株式数は何ですか。

Adaptimmune Therapeutics Plcの浮動株式数は0.000 0.00%です。

浮動株式数の定義は何ですか。

浮動株式数は、ロックインされた株式とは対照的に、公的投資家の手にある企業の株式の一部です。

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

NASDAQのセクタHealth Careにおける浮動株式数の企業と比べるAdaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plcは何をしますか。

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Adaptimmune Therapeutics Plcと類似の浮動株式数